View Older Stories View More Recent Stories
-
Tenet Healthcare (THC) Reiterated at Overweight by Cantor Fitzgerald After HCIT Survey
-
Tenet Healthcare (THC) Reiterated at Overweight by Cantor Fitzgerald - Set-up Attractive
-
Acadia Healthcare (ACHC) Reiterated at Neutral by Cantor Fitzgerald
-
TD Cowen: 'We est ~+3%/+2%/ +2%/+1% EBITDA pickup for HCA/UHS/THC/ACHC'
-
Tenet Healthcare (THC) PT Raised to $283 at Guggenheim
-
Tenet Healthcare (THC) PT Raised to $265 at Mizuho
-
RBC: "We estimate that the pending FL program would provide a ~$270MM EBITDA benefit for HCA'
-
Cantor Fitzgerald Reiterates Overweight Rating on Tenet Healthcare (THC), Stock a 'Top Provider Pick'
-
Tenet Healthcare (THC) PT Raised to $271 at Guggenheim
-
Tenet Healthcare (THC) PT Raised to $265 at Jefferies
-
Tenet Healthcare (THC) PT Raised to $250 at KeyBanc; 'Good Guide, Big Stock Move'
-
Tenet Healthcare (THC) Tops Q4 EPS by 68c ; Offers Guidance
-
UBS Reiterates Buy Rating on Tenet Healthcare (THC)
-
Truist Securities Reiterates Buy Rating on Tenet Healthcare (THC)
-
Tenet Healthcare (THC) PT Raised to $253 at RBC Capital
-
Tenet Healthcare completes $1.9 billion deal to regain full Conifer ownership
-
Tenet Healthcare (THC) PT Lowered to $230 at TD Cowen
-
Centene (CNC) Reiterated at Neutral by Cantor Fitzgerald
-
Acadia Healthcare (ACHC) Reiterated at Neutral by Cantor Fitzgerald
-
Tenet Healthcare (THC) Can Underperform, In-Line Guidance Bold - Cantor Fitzgerald
-
Tenet Healthcare board director Stephen Rusckowski resigns
-
Tenet Healthcare issues $2.25 billion in notes to refinance existing debt
-
Tenet Healthcare (THC) PT Raised to $250 at Raymond James
-
Tenet Healthcare (THC) PT Raised to $245 at Cantor Fitzgerald
-
Tenet Healthcare (THC) PT Raised to $238 at Guggenheim
-
Tenet Healthcare (THC) PT Raised to $246 at Goldman Sachs
-
Tenet Healthcare (THC) Tops Q3 EPS by 36c; offers guidance
-
Stocks expected to have increasing option volume: THC VFC CDNS FFIV UHS CFLT BBBY WHR FTAI NXPI SOLS KMX WM CR
-
Tenet Healthcare (THC) spreader of November 230 and 240 calls
-
Goldman Sachs Assumes Tenet Healthcare (THC) at Buy
-
Cantor Fitzgerald sees outpatient trends supporting Tenet Healthcare (THC)
-
Cantor Fitzgerald Reiterates Neutral Rating on Acadia Healthcare (ACHC)
-
Cantor Fitzgerald Reiterates Overweight Rating on Tenet Healthcare (THC)
-
Cantor Fitzgerald Reiterates Overweight Rating on Tenet Healthcare (THC)
-
Cantor Fitzgerald Reiterates Overweight Rating on Tenet Healthcare (THC)
-
Morgan Stanley unveils 16 ‘Vintage Values’ stocks for 2026
-
Universal Health (UHS), Others Falls Following Conf.
-
Morgan Stanley lists top value stocks to own for 2026
-
BofA Lists EHC and THC as Top Picks in Healthcare, Sees UHS and ARDT as Worst Positioned
-
Tenet Healthcare (THC) Stock PT Raised at RBC Capital on 'Strong Growth Potential'
-
Tenet Healthcare (THC) 3400 contracts of September 190 and 1800 contracts of September 200 calls trade
-
Cantor Fitzgerald Reiterates Neutral Rating on Universal Health Services (UHS)
-
Cantor Fitzgerald Reiterates Overweight Rating on Tenet Healthcare (THC)
-
Wolfe Research Downgrades Tenet Healthcare (THC) to Peerperform
-
Tenet Healthcare (THC) PT Raised to $190 at Cantor Fitzgerald
-
Tenet Healthcare (THC) PT Raised to $205 at BofA Securities
-
Tenet Healthcare (THC) PT Raised to $238 at UBS
-
Tenet Healthcare (THC) PT Raised to $200 at Raymond James
-
Tenet Healthcare (THC) Tops Q2 EPS by 114c; offers guidance
-
Cantor Fitzgerald Reiterates Overweight Rating on Tenet Healthcare (THC)

